Novo Nordisk Other Operating Income or Expenses 2010-2024 | NVO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novo Nordisk annual other operating income or expenses for 2024 were $-0.305B, a 1864.77% decline from 2023.
Novo Nordisk annual other operating income or expenses for 2023 were $0.017B, a 88.2% decline from 2022.
Novo Nordisk annual other operating income or expenses for 2022 were $0.146B, a 177.19% increase from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novo Nordisk annual other operating income or expenses for 2024 were $-0.305B, a 1864.77% decline from 2023.
Novo Nordisk annual other operating income or expenses for 2023 were $0.017B, a 88.2% decline from 2022.
Novo Nordisk annual other operating income or expenses for 2022 were $0.146B, a 177.19% increase from 2021.